UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting

PloS one, 2021-05, Vol.16 (5), p.e0251741-e0251741

2021

Link zum Volltext

Verfügbarkeit prüfen

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

The lancet. Gastroenterology & hepatology, 2022-09, Vol.7 (9), p.851-861

2022

Link zum Volltext

Verfügbarkeit prüfen

Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?

Annals of hepatology, 2022-05, Vol.27 (3), p.100703-100703, Article 100703

Congly, Stephen E.

2022

Link zum Volltext

Verfügbarkeit prüfen

Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset

Gastroenterology (New York, N.Y. 1943), 2024-02, Vol.166 (2), p.359-360

2024

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Alcohol‐related liver disease is the primary driver of cirrhosis‐related hospital admissions in the COVID‐19 era—What can be done?

Alimentary pharmacology & therapeutics, 2023-07, Vol.58 (2), p.260-261

2023

Link zum Volltext

Verfügbarkeit prüfen

Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management

Hepatology (Baltimore, Md.), 2019-06, Vol.69 (6), p.2683-2695

2019

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis E: an important entity for clinicians to be aware of

Canadian Medical Association journal (CMAJ), 2022-09, Vol.194 (37), p.E1292

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparing Magnetic Resonance Imaging and Contrast-Enhanced Ultrasound (CEUS) for the Characterization of Nodules Found on Hepatocellular Carcinoma Surveillance: CEUS is Our Clear Choice

Journal of ultrasound in medicine, 2023-06, Vol.42 (6), p.1175-1180

2023

Link zum Volltext

Verfügbarkeit prüfen

Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021

Annals of hepatology, 2024-07, Vol.29 (4), p.101509, Article 101509

2024

Link zum Volltext

Verfügbarkeit prüfen

Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis

Gastroenterology (New York, N.Y. 1943), 2021-01, Vol.160 (1), p.88-98.e4

2021

Link zum Volltext

Verfügbarkeit prüfen

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review

Nutrients, 2022-10, Vol.14 (21), p.4556

2022

Link zum Volltext

Verfügbarkeit prüfen

Quality standards on management of alcohol-related liver disease from the UK—targets and tribulations

Hepatobiliary surgery and nutrition, 2024-04, Vol.13 (2), p.336-342

2024

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Geographic Disparities in Gastrointestinal Cancer Mortality in the United States

Gastroenterology (New York, N.Y. 1943), 2022-08, Vol.163 (2), p.437-448.e1

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis

Scientific reports, 2021-09, Vol.11 (1), p.17787-17787, Article 17787

2021

Link zum Volltext

Verfügbarkeit prüfen

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B

Viruses, 2021-07, Vol.13 (7), p.1318

2021

Link zum Volltext

Verfügbarkeit prüfen

Distinguishing Between Sex and Gender Is Critical for Research in Transplantation

Transplantation, 2020-02, Vol.104 (2), p.e57

2020

Link zum Volltext

Verfügbarkeit prüfen

A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C

Journal of hepatology, 2023-08, Vol.79 (2), p.314-320

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada

Clinical gastroenterology and hepatology, 2022-05, Vol.20 (5), p.e1170-e1179

2022

Link zum Volltext

Verfügbarkeit prüfen

Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data

Gastroenterology (New York, N.Y. 1943), 2020-02, Vol.158 (3), p.780-782.e3

2020

Link zum Volltext

Verfügbarkeit prüfen

Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy

Liver transplantation, 2016-06, Vol.22 (6), p.723-731

2016

Link zum Volltext

Verfügbarkeit prüfen

Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States

Liver international, 2019-05, Vol.39 (5), p.878-884

2019

Link zum Volltext

Verfügbarkeit prüfen

Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016

The American journal of gastroenterology, 2021-10, Vol.116 (10), p.2060-2067

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of acute hepatitis C virus is cost‐effective but at what price?

Hepatology (Baltimore, Md.), 2018-04, Vol.67 (4), p.1640-1641

2018

Link zum Volltext

Verfügbarkeit prüfen

Intermittent Proton Pump Inhibitor Therapy in Low-Risk Non-Variceal Upper Gastrointestinal Bleeding May Be Significantly Cost-Saving

Medicines (Basel, Switzerland), 2023-07, Vol.10 (7), p.44

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(82)
Berichte
(1)

Sprache

Englisch
(83)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?

Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset

Editorial: Alcohol‐related liver disease is the primary driver of cirrhosis‐related hospital admissions in the COVID‐19 era—What can be done?

Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management

Chronic hepatitis E: an important entity for clinicians to be aware of

Comparing Magnetic Resonance Imaging and Contrast-Enhanced Ultrasound (CEUS) for the Characterization of Nodules Found on Hepatocellular Carcinoma Surveillance: CEUS is Our Clear Choice

Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021

Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review

Quality standards on management of alcohol-related liver disease from the UK—targets and tribulations

Factors Associated With Geographic Disparities in Gastrointestinal Cancer Mortality in the United States

Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B

Distinguishing Between Sex and Gender Is Critical for Research in Transplantation

A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C

Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada

Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data

Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy

Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States

Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016

Treatment of acute hepatitis C virus is cost‐effective but at what price?

Intermittent Proton Pump Inhibitor Therapy in Low-Risk Non-Variceal Upper Gastrointestinal Bleeding May Be Significantly Cost-Saving

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)

Suchergebnisse filtern